System and method for providing closely-followed cardiac therapy management through automated patient care

• US 20070219419A1
• Filed: 03/17/2006
• Published: 09/20/2007
• Est. Priority Date: 03/17/2006
• Status: Active Grant

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Manicka, Yatheendhar, KenKnight, Bruce
• Granted Patent: US 7,996,074 B2
• Time in Patent Office: Days
• US Class Current: 600/300
• CPC Class Codes: A61B 5/0006 ECG or EEG signals
• CPC Class Codes: A61B 5/0031 Implanted circuitry

Abstract

A system and method for providing closely-followed cardiac therapy management through automated patient care is presented. A patient under remote care is enrolled in a monitoring program following commencement of a cardiac therapy regimen to be undertaken by the patient. A wearable monitor, including one or more patient physiology sensors and a wireless interface providing enabling bi-directional data exchange, is provided to the patient. Patient physiometry, including quantitative physiological measures, is periodically collected from the wearable monitor over the wireless interface concomitant to performance of the cardiac therapy regimen. The patient physiometry is evaluated to determine a trend indicating an onset, progression, regression, absence of, and status quo of patient health status.

Claims

1. A system for providing closely-followed cardiac therapy management through automated patient care, comprising:

a wearable monitor comprising one or more patient physiology sensors and a wireless interface providing enabling bi-directional data exchange; and

a monitoring server, comprising;

a monitoring program to enroll a patient under remote care in following commencement of a cardiac therapy regimen to be undertaken by the patient;

a telemetry interface to periodically collect patient physiometry comprising quantitative physiological measures from the wearable monitor over the wireless interface concomitant to performance of the cardiac therapy regimen; and

a data processor to evaluate the patient physiometry to determine a trend indicating an onset, progression, regression, absence of, and status quo of patient health status.

2. A system according to claim 1, further comprising:

predefined alert conditions to be compared to the trend; and

a notifier to generate a notification if at least one predefined alert condition is met.

3. A system according to claim 1, further comprising:

an analyzer to perform processing of the patient physiology comprising at least one of statistical analysis, value reduction and derivation, data extrapolation, and threshold evaluation.

4. A system according to claim 1, wherein one or more patient groups are formed that each comprise sets of the qualitative physiological measures for a plurality of patients.

5. A system according to claim 4, further comprising:

an analyzer to analyze the qualitative physiological measures sets in the patient groups based on one or more of pre-treatment phenotype, therapeutic response, and medication administered.

6. A system according to claim 1, further comprising:

an analyzer to process the initial physiological measures set in a reference baseline indicating an initial patient health status, wherein the patient physiology collected during an initial time period are grouped into an initial physiological measures set.

7. A system according to claim 1, further comprising:

an analyzer to evaluate the quality of life physiometry as part of determining the patient health status, wherein quality of life physiometry is collected comprising qualitative physiological measures from the wearable monitor over the wireless interface concomitant to performance of the cardiac therapy regimen.

8. A system according to claim 1, wherein the quantitative physiological measures are collected by the wearable monitor on at least one of a continuous and intermittent basis.

9. A system according to claim 1, wherein the physiological measures are selected from the group comprising heart rate, heart rate variability, heart rate variability minimum, heart rate variability maximum, heart rate variability mean, physical activity, and medical therapy compliance.

10. A system according to claim 1, wherein the cardiac therapy regimen is selected from the group comprising medication, dietary restriction or modification, and physical activity restriction.

11. An method for providing closely-followed cardiac therapy management through automated patient care, comprising:

enrolling a patient under remote care in a monitoring program following commencement of a cardiac therapy regimen to be undertaken by the patient;

providing a wearable monitor comprising one or more patient physiology sensors and a wireless interface providing enabling bi-directional data exchange;

periodically collecting patient physiometry comprising quantitative physiological measures from the wearable monitor over the wireless interface concomitant to performance of the cardiac therapy regimen; and

evaluating the patient physiometry to determine a trend indicating an onset, progression, regression, absence of, and status quo of patient health status.

12. A method according to claim 11, further comprising:

comparing the trend to predefined alert conditions; and

generating a notification if at least one predefined alert condition is met.

13. A method according to claim 11, further comprising:

performing processing of the patient physiology comprising at least one of statistical analysis, value reduction and derivation, data extrapolation, and threshold evaluation.

14. A method according to claim 11, further comprising:

forming one or more patient groups that each comprise sets of the qualitative physiological measures for a plurality of patients.

15. A method according to claim 14, further comprising:

analyzing the qualitative physiological measures sets in the patient groups based on one or more of pre-treatment phenotype, therapeutic response, and medication administered.

16. A method according to claim 11, further comprising:

grouping the patient physiology collected during an initial time period into an initial physiological measures set; and

processing the initial physiological measures set in a reference baseline indicating an initial patient health status.

17. A method according to claim 11, further comprising:

collecting quality of life physiometry comprising qualitative physiological measures from the wearable monitor over the wireless interface concomitant to performance of the cardiac therapy regimen; and

evaluating the quality of life physiometry as part of determining the patient health status.

18. A method according to claim 11, wherein the quantitative physiological measures are collected by the wearable monitor on at least one of a continuous and intermittent basis.

19. A method according to claim 11, wherein the physiological measures are selected from the group comprising heart rate, heart rate variability, heart rate variability minimum, heart rate variability maximum, heart rate variability mean, physical activity, and medical therapy compliance.

20. A method according to claim 11, wherein the cardiac therapy regimen is selected from the group comprising medication, dietary restriction or modification, and physical activity restriction.

21. A computer-readable storage medium holding code for performing the method according to claim 11.

22. An apparatus for providing closely-followed cardiac therapy management through automated patient care, comprising:

means for enrolling a patient under remote care in a monitoring program following commencement of a cardiac therapy regimen to be undertaken by the patient;

means for providing a wearable monitor comprising one or more patient physiology sensors and a wireless interface providing enabling bi-directional data exchange;

means for periodically collecting patient physiometry comprising quantitative physiological measures from the wearable monitor over the wireless interface concomitant to performance of the cardiac therapy regimen; and

means for evaluating the patient physiometry to determine a trend indicating an onset, progression, regression, absence of, and status quo of patient health status.